Equibles does not estimate personal net worth.
Devanthi has spoken on 1 earnings call across 1 company, most recently for Sun Pharmaceutical Industries Limited on January 31, 2026. The companies whose calls Devanthi spoke on are classified in the Healthcare sector.
“In your opening remarks, you mentioned better mix led to such strong gross margin. So, if you can just explain, like, what are the key drivers to sustain such high gross margin, as we understand now, rev limit benefit is over for you.”
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharma Q3 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
